The apoM-S1P axis in hepatic diseases

Area of Science:

• Biochemistry
• Hepatology
• Lipid Metabolism

Background:

• Liver dysfunction is closely linked to disruptions in lipid metabolism.
• Apolipoprotein M (apoM) is a liver-secreted protein crucial for lipid transport.
• apoM primarily chaperones sphingosine-1-phosphate (S1P), a vital signaling molecule.

Purpose of the Study:

• To review the multifaceted roles of the apoM-S1P axis in various hepatic diseases.
• To summarize current understanding of apoM and S1P in liver disease pathogenesis.
• To discuss emerging diagnostic and therapeutic strategies targeting the apoM-S1P pathway.

Main Methods:

• Literature review of studies investigating apoM and S1P in liver conditions.
• Analysis of the physiological and pathophysiological functions of apoM and S1P.
• Synthesis of research on the apoM-S1P axis in hepatic disease models and human studies.

Main Results:

• The apoM-S1P axis is implicated in diverse hepatic diseases, including fibrosis, viral hepatitis, steatohepatitis, and cancer.
• apoM influences S1P bioavailability and biological activities, impacting liver health.
• Dysregulation of apoM and S1P is a common feature across various liver pathologies.

Conclusions:

• The apoM-S1P axis represents a significant factor in the development and progression of liver diseases.
• Targeting the apoM-S1P pathway holds promise for novel diagnostic and therapeutic interventions in hepatology.
• Further research into the precise mechanisms of apoM-S1P in liver disease is warranted.